Capecitabine (Oral Route)

3 imperatives to transform health care in America. You're invited to watch it live

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Capecitabine (Oral Route)

Drug Information provided by: Micromedex

US Brand Names

  • Xeloda

Description

Capecitabine is used to treat breast cancer and colorectal cancer (cancer of the colon or rectum). Capecitabine belongs to the group of medicines called antineoplastics (cancer medicines).

Capecitabine interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal cells may also be affected by the medicine, other side effects may also occur. Some of these may be serious and must be reported to your doctor.

This medicine is available only with your doctor's prescription.

Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, capecitabine is used in certain patients with the following medical conditions:

  • Advanced or metastatic stomach cancer (cancer that has spread to other areas of the body), first-line therapy.
  • Metastatic colorectal cancer (cancer of the colon or rectum that has spread to other areas of the body), first-line therapy, in combination with bevacizumab and oxaliplatin.
  • Gastric cancer (stomach cancer), stage II to IIIB, in combination with oxaliplatin.

This product is available in the following dosage forms:

  • Tablet
Before Using
DR600289 Portions of this document last updated: Aug. 1, 2012

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger